Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study - Aleil, B; Jacquemin, L; De Poli, F (JACC Cardiovasc Interv, 2008)